Serum thrombomodulin level can distinguish between patients with active LN and healthy subjects and patients with active non-renal SLE but did not show a high specificity in distinguishing LN patient and CKD patients suggesting that increased thrombomodulin level may be a potential biomarker of kidney damage (53). This evidence concerns the gene THBD and lobular neoplasia.